Late toxicity following stereotactic radiotherapy (SABR) for central and ultracentral lung tumors

被引：0
|
作者：
Tekatli, H. [1 ]
Lagerwaard, F. [1 ]
van Eekelen, R. [2 ]
Senan, S. [1 ]
机构：
[1] Amsterdam UMC, Radiat Oncol, Amsterdam, Netherlands
[2] Amsterdam UMC, Dept Epidemiol & Data Sci, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0609
引用
收藏
页码：S493 / S494
页数：2
相关论文
共 50 条
  • [1] Safety of Stereotactic Body Radiotherapy for Central, Ultracentral, and Paramediastinal Lung Tumors
    Daly, Megan
    Novak, Jennifer
    Monjazeb, Arta
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1066 - S1066
  • [2] The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors
    Chang, Joe H.
    Poon, Ian
    Erler, Darby
    Zhang, Liying
    Cheung, Patrick
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 277 - 283
  • [3] Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
    Regnery, Sebastian
    Eichkorn, Tanja
    Weykamp, Fabian
    Held, Thomas
    Dinges, Lisa-Antonia
    Schunn, Fabian
    Winter, Hauke
    Thomas, Michael
    Debus, Jurgen
    El Shafie, Rami A.
    Adeberg, Sebastian
    Hoerner-Rieber, Juliane
    [J]. CANCERS, 2020, 12 (10) : 1 - 14
  • [4] Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
    Owen, Dawn
    Sio, Terence T.
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (11) : 7024 - 7031
  • [5] Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
    Chaudhuri, Aadel A.
    Tang, Chad
    Binkley, Michael S.
    Jin, Michelle
    Wynne, Jacob F.
    von Eyben, Rie
    Hara, Wendy Y.
    Trakul, Nicholas
    Loo, Billy W., Jr.
    Diehn, Maximilian
    [J]. LUNG CANCER, 2015, 89 (01) : 50 - 56
  • [6] Tumor Control and Toxicity Following SBRT for Ultracentral, Central and Paramediastinal Lung Tumors
    Nguyen, K. N. B.
    Hause, D.
    Novak, J.
    Monjazeb, A. M.
    Daly, M. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E699 - E699
  • [7] Ten years outcomes after SABR in central and ultracentral primary lung tumors
    Tekatli, Hilal
    Giraud, Nicolas
    van Eekelen, Rik
    Lagerwaard, Frank J.
    Senan, Suresh
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 188
  • [8] Stereotactic radiotherapy for ultracentral lung tumours
    Bourbonne, V.
    Thureau, S.
    Pradier, O.
    Antoni, D.
    Lucia, F.
    [J]. CANCER RADIOTHERAPIE, 2023, 27 (6-7): : 659 - 665
  • [9] Oncological Results and Toxicities of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors
    Yakar, Melek
    Etiz, Durmus
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2024, 34 (02): : 84 - 92
  • [10] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
    Tekatli, H.
    Tetar, S.
    Warner, A.
    Palma, D.
    Verbakel, W.
    Nguyen, T.
    Spoelstra, F.
    Gaede, S.
    Slotman, B.
    Senan, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143
12345